Evidence map›Paper›PMID 38771535›Full record

ArticleJournal of general internal medicine2024

Patterns of Care Following a Positive Fecal Blood Test for Colorectal Cancer: A Mixed Methods Study.

Erin E Hahn, Corrine E Munoz-Plaza, Christopher D Jensen, Nirupa R Ghai, Katherine Pak, Britta I Amundsen, Richard Contreras, Nancy Cannizzaro, Jessica Chubak, Beverly B Green and 4 more

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Erin E HahnDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. Erin.E.Hahn@kp.org.ORCID 0000-0002-8419-2331
Corrine E Munoz-PlazaDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Christopher D JensenKaiser Permanente Division of Research, Oakland, CA, USA.
Nirupa R GhaiDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Katherine PakDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Britta I AmundsenDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Richard ContrerasDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Nancy CannizzaroDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
Jessica ChubakKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Beverly B GreenKaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Celette Sugg SkinnerPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ethan A HalmDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Joanne E SchottingerDepartment of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Theodore R LevinKaiser Permanente Division of Research, Oakland, CA, USA.

Funding

PROSPR METRICS CISNET Collaboration Investigating Impact of Structural Racism/Discrimination on Cervical Screening Moonshot SupplementUM1CA221940 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI CHUBAK, JESSICA, HAAS, JENNIFER S · 2018 to 2023
$15.9M
Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)UM1CA222035 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI CHUBAK, JESSICA, CORLEY, DOUGLAS ALLEN · 2018 to 2023
$15.6M
Division of Cancer Epidemiology and Genetics, National Cancer Institute UM1 CA222035 /UM1 CA221940NCI NIH HHS UM1 CA221940NCI NIH HHS UM1 CA222035
6 · The paper itself

Abstract

BACKGROUND/

objectiveMultilevel barriers to colonoscopy after a positive fecal blood test for colorectal cancer (CRC) are well-documented. A less-explored barrier to appropriate follow-up is repeat fecal testing after a positive test. We investigated this phenomenon using mixed methods.

designThis sequential mixed methods study included quantitative data from a large cohort of patients 50-89 years from four healthcare systems with a positive fecal test 2010-2018 and qualitative data from interviews with physicians and patients. MAIN MEASURES: Logistic regression was used to evaluate whether repeat testing was associated with failure to complete subsequent colonoscopy and to identify factors associated with repeat testing. Interviews were coded and analyzed to explore reasons for repeat testing. KEY

resultsA total of 316,443 patients had a positive fecal test. Within 1 year, 76.3% received a colonoscopy without repeat fecal testing, 3% repeated testing and then received a colonoscopy, 4.4% repeated testing without colonoscopy, and 16.3% did nothing. Among repeat testers (7.4% of total cohort, N = 23,312), 59% did not receive a colonoscopy within 1 year. In adjusted models, those with an initial positive test followed by a negative second test were significantly less likely to receive colonoscopy than those with two successive positive tests (OR 0.37, 95% CI 0.35-0.40). Older age (65-75 vs. 50-64 years: OR 1.37, 95% CI 1.33-1.41) and higher comorbidity score (≥ 4 vs. 0: OR 1.75, 95% CI 1.67-1.83) were significantly associated with repeat testing compared to those who received colonoscopy without repeat tests. Qualitative interview data revealed reasons underlying repeat testing, including colonoscopy avoidance, bargaining, and disbelief of positive results.

conclusionsAmong patients in this cohort, 7.4% repeated fecal testing after an initial positive test. Of those, over half did not go on to receive a colonoscopy within 1 year. Efforts to improve CRC screening must address repeat fecal testing after a positive test as a barrier to completing colonoscopy.

Indexed as

ColonoscopyColorectal NeoplasmsEarly Detection of CancerOccult BloodAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle Agedbarriers to colonoscopycolorectal cancer screeningfecal blood testingmixed methods

Identifiers

PMID38771535
PMCPMC11618562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.